Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 6342104, 21 pages
https://doi.org/10.1155/2019/6342104
Research Article

BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells

1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan
2School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
3Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung 80145, Taiwan
5Department of Orthopaedic Surgery, Ping-Tung Christian Hospital, Pingtung 90059, Taiwan
6Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan
7Department of Obstetrics and Gynecology and Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
8Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
9Doctoral Degree Program in Marine Biotechnology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
10Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan
11National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan
12Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
13Center for Neuroscience, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
14Department of Neurosurgery and Surgery, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan
15Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan

Correspondence should be addressed to Nan-Fu Chen; moc.liamg@88660nehc and Hsiao-Mei Kuo; moc.liamg@oukiemoaish

Received 16 September 2018; Revised 11 January 2019; Accepted 30 January 2019; Published 7 May 2019

Academic Editor: Sander Bekeschus

Copyright © 2019 Meng-Hsuan Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The American Cancer Society medical and editorial content team, “Key statistics for lung cancer,” January, 2018 May, 2018, https://www.cancer.org/cancer/non-small-cell-lung-cancer/about/key-statistics.html.
  2. C. J. Chiang, W. C. Lo, Y. W. Yang, S. L. You, C. J. Chen, and M. S. Lai, “Incidence and survival of adult cancer patients in Taiwan, 2002-2012,” Journal of the Formosan Medical Association, vol. 115, no. 12, pp. 1076–1088, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. E. R. Roberts and K. J. Thomas, “The role of mitochondria in the development and progression of lung cancer,” Computational and Structural Biotechnology Journal, vol. 6, no. 7, article e201303019, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Rolfo, F. Passiglia, M. Ostrowski et al., “Improvement in lung cancer outcomes with targeted therapies: an update for family physicians,” Journal of American Board of Family Medicine, vol. 28, no. 1, pp. 124–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Y. Hsu, T. Y. Lin, M. K. Lu, P. J. Leng, S. M. Tsao, and Y. C. Wu, “Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer,” Scientific Reports, vol. 7, no. 1, article 44990, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Shalini, L. Dorstyn, S. Dawar, and S. Kumar, “Old, new and emerging functions of caspases,” Cell Death and Differentiation, vol. 22, no. 4, pp. 526–539, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Vyas, E. Zaganjor, and M. C. Haigis, “Mitochondria and cancer,” Cell, vol. 166, no. 3, pp. 555–566, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Hüttemann, S. Helling, T. H. Sanderson et al., “Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1817, no. 4, pp. 598–609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Redza-Dutordoir and D. A. Averill-Bates, “Activation of apoptosis signalling pathways by reactive oxygen species,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1863, no. 12, pp. 2977–2992, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Tan, H. Xiao, F. Li, L. Zeng, and Y. Yin, “The profiles of mitochondrial respiration and glycolysis using extracellular flux analysis in porcine enterocyte IPEC-J2,” Animal Nutrition, vol. 1, no. 3, pp. 239–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Yadav, S. Kumar, T. Marlowe et al., “Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents,” Cell Death & Disease, vol. 6, no. 11, article e1969, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Y. Wu, P. J. Sung, Y. L. Chang, S. L. Pan, and C. M. Teng, “Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells,” BioMed Research International, vol. 2015, Article ID 738241, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Wu, C. T. Wang, H. C. Hung et al., “Heteronemin is a novel c-Met/STAT3 inhibitor against advanced prostate cancer cells,” Prostate, vol. 76, no. 16, pp. 1469–1483, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kopf, K. Viola, A. G. Atanasov et al., “In vitro characterisation of the anti-intravasative properties of the marine product heteronemin,” Archives of Toxicology, vol. 87, no. 10, pp. 1851–1861, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. W. M. Alarif, S. S. al-Lihaibi, M. A. Ghandourah, M. I. Orif, S. A. Basaif, and S. E. N. Ayyad, “Cytotoxic scalarane-type sesterterpenes from the Saudi Red Sea sponge Hyrtios erectus,” Journal of Asian Natural Products Research, vol. 18, no. 6, pp. 611–617, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Rasola and P. Bernardi, “The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis,” Apoptosis, vol. 12, no. 5, pp. 815–833, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Miriyala, I. Spasojevic, A. Tovmasyan et al., “Manganese superoxide dismutase, MnSOD and its mimics,” Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, vol. 1822, no. 5, pp. 794–814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Chipuk and D. R. Green, “How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?” Trends in Cell Biology, vol. 18, no. 4, pp. 157–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. D’Amelio, M. Sheng, and F. Cecconi, “Caspase-3 in the central nervous system: beyond apoptosis,” Trends in Neurosciences, vol. 35, no. 11, pp. 700–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Ni, T. Cao, S. Xiong et al., “Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy,” Free Radical Biology & Medicine, vol. 90, pp. 12–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2017,” CA: A Cancer Journal for Clinicians, vol. 67, no. 1, pp. 7–30, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Lin and A. T. Shaw, “Resisting resistance: targeted therapies in lung cancer,” Trends in Cancer, vol. 2, no. 7, pp. 350–364, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Riihimäki, A. Hemminki, M. Fallah et al., “Metastatic sites and survival in lung cancer,” Lung Cancer, vol. 86, no. 1, pp. 78–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Y. Lin, S. L. Tey, Y. Ho et al., “Heteronemin induces anti-proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway,” Marine Drugs, vol. 16, no. 12, 2018. View at Publisher · View at Google Scholar · View at Scopus
  25. H. H. Huang, S. M. Kuo, Y. J. Wu, and J. H. Su, “Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation,” International Journal of Nanomedicine, vol. 11, pp. 1237–1251, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. C. Chen, M. C. Lu, M. el-Shazly et al., “Breaking down leukemia walls: heteronemin, a sesterterpene derivative, induces apoptosis in leukemia Molt 4 cells through oxidative stress, mitochondrial dysfunction and induction of talin expression,” Marine Drugs, vol. 16, no. 6, 2018. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Saikia, A. P. Retnakumari, S. Anwar et al., “Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras,” Oncotarget, vol. 9, no. 26, pp. 18115–18127, 2018. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. Mace, S. J. Riedl, and G. S. Salvesen, “Caspase enzymology and activation mechanisms,” Methods in Enzymology, vol. 544, pp. 161–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Ichim and S. W. G. Tait, “A fate worse than death: apoptosis as an oncogenic process,” Nature Reviews Cancer, vol. 16, no. 8, pp. 539–548, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. N. S. Wilson, V. Dixit, and A. Ashkenazi, “Death receptor signal transducers: nodes of coordination in immune signaling networks,” Nature Immunology, vol. 10, no. 4, pp. 348–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Wajant, “Principles and mechanisms of CD95 activation,” Biological Chemistry, vol. 395, no. 12, pp. 1401–1416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Chipuk, L. Bouchier-Hayes, and D. R. Green, “Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario,” Cell Death and Differentiation, vol. 13, no. 8, pp. 1396–1402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. P. McStay and D. R. Green, “Preparation of cytosolic extracts and activation of caspases by cytochrome c,” Cold Spring Harbor Protocols, vol. 2014, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Lee, Y. C. Liu, Y. L. Lee et al., “Heteronemin, a marine sesterterpenoid-type metabolite, induces apoptosis in prostate LNcap cells via oxidative and ER stress combined with the inhibition of topoisomerase II and Hsp90,” Marine Drugs, vol. 16, no. 6, 2018. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Fulda, “Targeting apoptosis for anticancer therapy,” Seminars in Cancer Biology, vol. 31, pp. 84–88, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. D. C. Chan, “Fusion and fission: interlinked processes critical for mitochondrial health,” Annual Review of Genetics, vol. 46, no. 1, pp. 265–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Ahn, K. I. Kim, G. Kim, E. Moon, S. S. Yang, and J. S. Lee, “Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals,” PLoS One, vol. 6, no. 11, article e28154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Vandamme, E. Robert, S. Lerondel et al., “ROS implication in a new antitumor strategy based on non-thermal plasma,” International Journal of Cancer, vol. 130, no. 9, pp. 2185–2194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Köritzer, V. Boxhammer, A. Schäfer et al., “Restoration of sensitivity in chemo — resistant glioma cells by cold atmospheric plasma,” PLoS One, vol. 8, no. 5, article e64498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Barrera, “Oxidative stress and lipid peroxidation products in cancer progression and therapy,” ISRN Oncology, vol. 2012, Article ID 137289, 21 pages, 2012. View at Publisher · View at Google Scholar
  41. C. Borek, “Antioxidant health effects of aged garlic extract,” The Journal of Nutrition, vol. 131, no. 3, pp. 1010S–1015S, 2001. View at Publisher · View at Google Scholar
  42. P. L. de Sá Junior, D. A. D. Câmara, A. S. Porcacchia et al., “The roles of ROS in cancer heterogeneity and therapy,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2467940, 12 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Ranjan, N. M. Fofaria, S. H. Kim, and S. K. Srivastava, “Modulation of signal transduction pathways by natural compounds in cancer,” Chinese Journal of Natural Medicines, vol. 13, no. 10, pp. 730–742, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar · View at Scopus
  45. W. H. Koppenol, P. L. Bounds, and C. V. Dang, “Otto Warburg’s contributions to current concepts of cancer metabolism,” Nature Reviews Cancer, vol. 11, no. 5, pp. 325–337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. W. X. Zong, J. D. Rabinowitz, and E. White, “Mitochondria and cancer,” Molecular Cell, vol. 61, no. 5, pp. 667–676, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. T. M. Ashton, W. G. McKenna, L. A. Kunz-Schughart, and G. S. Higgins, “Oxidative phosphorylation as an emerging target in cancer therapy,” Clinical Cancer Research, vol. 24, no. 11, pp. 2482–2490, 2018. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Bagkos, K. Koufopoulos, and C. Piperi, “A new model for mitochondrial membrane potential production and storage,” Medical Hypotheses, vol. 83, no. 2, pp. 175–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. S. V. Brown, P. Hosking, J. Li, and N. Williams, “ATP synthase is responsible for maintaining mitochondrial membrane potential in bloodstream form Trypanosoma brucei,” Eukaryotic Cell, vol. 5, no. 1, pp. 45–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Wang, M. F. Green, E. McDonnell, and M. D. Hirschey, “Oxygen flux analysis to understand the biological function of sirtuins,” Methods in Molecular Biology, vol. 1077, pp. 241–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. A. E. Dikalova, A. T. Bikineyeva, K. Budzyn et al., “Therapeutic targeting of mitochondrial superoxide in hypertension,” Circulation Research, vol. 107, no. 1, pp. 106–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. H. L. Liang, F. Sedlic, Z. Bosnjak, and V. Nilakantan, “SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery,” Free Radical Biology & Medicine, vol. 49, no. 10, pp. 1550–1560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Trnka, F. H. Blaikie, R. A. J. Smith, and M. P. Murphy, “A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria,” Free Radical Biology & Medicine, vol. 44, no. 7, pp. 1406–1419, 2008. View at Publisher · View at Google Scholar · View at Scopus